Our Specialties
Our small experienced team allows us to offer a bespoke service applying all our expertise in conducting medical device clinical studies for both pre- and post-marketing medical studies.
We offer experience in flexible approaches to clinical trial design, incorporating decentralised trials and providing an alternative to the site-anchored systems which have high drop-out rates
Patient-centricity is our speciality, working with patients at an early stage is integral to understanding their needs and reducing the burden on participation, delivering better patient experience and retention rate
You’ll work closely with our team to understand the challenges to overcome to design and deliver a robust cost-efficient study
Our Customers Benefit From:
Operational and Regulatory team with significant experience of UK based medical device studies
Expertise in decentralised trials, including flexible combinations of virtual, home, remote and on-site, to optimise recruitment and retention rates
Risk-based monitoring approach to optimise cost whilst ensuring high-quality data.
Small bespoke team with experience of offering value for money, through working together to design and deliver an affordable study without those large company CRO costs.
Established relationships with primary, secondary clinical research sites, key opinion leaders to support your medical device trial
Patients Matter
The needs of every patient matters and their contribution to the overall design and ongoing improvement of any clinical trial is our goal
Working Together
We understand you value your product and the importance of working closely together to achieve your goals
Focus
Working in a small team enables us to concentrate fully on your trial and treat it as our own
Trust
We aspire to be honest and open in everything we do, so you can be confident in putting your trust in us
Why Choose a Decentralised Clinical Trial?
Decentralisation aims to make clinical trial participation as easy as possible; it enables participants to take part but continue with their normal day-to-day life with the least disruption.
- 70% of patients live more than two hours from a research site
- 50% of clinical trials find their participants struggle with poor health and staying enrolled
- 85% of trials fail to retain enough patients
Patients have busy lives, requiring them to attend on-site visits with often extensive travel times and costs can be unreasonable
A decentralised or hybrid clinical trial with a mix of both remote and on-site visits can impact clinical trial significantly: